• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过临床测序分析癌症基因组中与种族相关的突变的景观和饱和度。

Landscape and Saturation Analysis of Mutations Associated With Race in Cancer Genomes by Clinical Sequencing.

机构信息

University of Texas Southwestern Medical School, Dallas, TX, USA.

Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

出版信息

Oncologist. 2024 Mar 4;29(3):219-226. doi: 10.1093/oncolo/oyad341.

DOI:10.1093/oncolo/oyad341
PMID:38297963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10911917/
Abstract

Differences in cancer genomes between racial groups may impact tumor biology and health disparities. However, the discovery of race-associated mutations is constrained by the limited representation and sample size of different racial groups in prior genomic studies. We evaluated the influence of race on the frequency of gene mutations using the Genomics, Evidence, Neoplasia, Information, Exchange database, a large genomic dataset aggregated from clinical sequencing. Matched cohort analyses were used to identify histology-specific race-associated mutations including increased TERT promoter mutations in Black and Asian patients with gliomas and bladder cancers, and a decreased frequency of mutations in DNA repair pathway genes and subunits of the SWI/SNF chromatin complex in Asian and Black patients across multiple cancer types. The distribution of actionable mutations in oncogenes was also race-specific, demonstrating how targeted therapies may have a disparate impact on racial groups. Down-sampling analyses indicate that larger sample sizes are likely to discover more race-associated mutations. These results provide a resource to understand differences in cancer genomes between racial groups which may inform the design of clinical studies and patient recruitment strategies in biomarker trials.

摘要

不同种族之间的癌症基因组差异可能会影响肿瘤生物学和健康差异。然而,种族相关突变的发现受到先前基因组研究中不同种族群体代表性和样本量有限的限制。我们使用从临床测序中汇集的大型基因组数据集——Genomics, Evidence, Neoplasia, Information, Exchange 数据库,评估了种族对基因突变频率的影响。匹配队列分析用于确定组织学特异性的种族相关突变,包括黑人患者和亚洲患者的胶质瘤和膀胱癌中 TERT 启动子突变增加,以及亚洲患者和黑人患者中多个癌症类型的 DNA 修复途径基因和 SWI/SNF 染色质复合物亚基的突变频率降低。致癌基因中可操作突变的分布也是种族特异性的,表明靶向治疗可能对不同种族群体产生不同的影响。下采样分析表明,更大的样本量可能会发现更多的种族相关突变。这些结果提供了一个资源,以了解不同种族之间的癌症基因组差异,这可能为生物标志物试验中的临床研究和患者招募策略的设计提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15b/10911917/cff3918ddb07/oyad341_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15b/10911917/8e174340a60b/oyad341_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15b/10911917/0e6ab353cfc4/oyad341_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15b/10911917/cff3918ddb07/oyad341_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15b/10911917/8e174340a60b/oyad341_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15b/10911917/0e6ab353cfc4/oyad341_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15b/10911917/cff3918ddb07/oyad341_fig3.jpg

相似文献

1
Landscape and Saturation Analysis of Mutations Associated With Race in Cancer Genomes by Clinical Sequencing.通过临床测序分析癌症基因组中与种族相关的突变的景观和饱和度。
Oncologist. 2024 Mar 4;29(3):219-226. doi: 10.1093/oncolo/oyad341.
2
Under-Representation of Racial Groups in Genomics Studies of Gastroenteropancreatic Neuroendocrine Neoplasms.胃肠胰神经内分泌肿瘤基因组学研究中种族群体代表性不足。
Cancer Res Commun. 2022 Oct 12;2(10):1162-1173. doi: 10.1158/2767-9764.CRC-22-0093. eCollection 2022 Oct.
3
Racial/Ethnic Disparities in Genomic Sequencing.种族/民族在基因组测序中的差异。
JAMA Oncol. 2016 Aug 1;2(8):1070-4. doi: 10.1001/jamaoncol.2016.1854.
4
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.原发性和继发性肌层浸润性膀胱癌之间的基因组差异是基于顺铂为基础的新辅助化疗疗效差异的基础。
Eur Urol. 2019 Feb;75(2):231-239. doi: 10.1016/j.eururo.2018.09.002. Epub 2018 Oct 2.
5
ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?ARID1A 缺陷型尿路上皮膀胱癌:EZH2 抑制剂治疗反应的预测生物标志物?
PLoS One. 2018 Aug 23;13(8):e0202965. doi: 10.1371/journal.pone.0202965. eCollection 2018.
6
Genomic profiling of ovarian clear cell carcinoma in Chinese patients reveals potential prognostic biomarkers for survival.对中国患者卵巢透明细胞癌的基因组分析揭示了潜在的与生存相关的预后生物标志物。
Ann Med. 2023 Dec;55(1):2218104. doi: 10.1080/07853890.2023.2218104.
7
High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins.TERT启动子突变在膀胱小细胞癌中频率较高,但在其他起源的小细胞癌中并非如此。
J Hematol Oncol. 2014 Jul 20;7:47. doi: 10.1186/s13045-014-0047-7.
8
Is Our Science Representative? A Systematic Review of Racial and Ethnic Diversity in Orthopaedic Clinical Trials from 2000 to 2020.我们的科学具有代表性吗?一项针对 2000 年至 2020 年骨科临床试验中种族和民族多样性的系统评价。
Clin Orthop Relat Res. 2022 May 1;480(5):848-858. doi: 10.1097/CORR.0000000000002050. Epub 2021 Dec 2.
9
Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy.非小细胞肺癌中 SWI/SNF 染色质重塑因子的失调:对包括免疫疗法在内的癌症疗法的影响。
Biomolecules. 2023 Jun 13;13(6):984. doi: 10.3390/biom13060984.
10
Exploring the complexity and spectrum of racial/ethnic disparities in colon cancer management.探讨结肠癌管理中种族/民族差异的复杂性和范围。
Int J Equity Health. 2023 Apr 14;22(1):68. doi: 10.1186/s12939-023-01883-w.

引用本文的文献

1
Prevalence of targetable genomic alterations among a diverse population participating in the ASCO TAPUR Study.参加美国临床肿瘤学会(ASCO)TAPUR研究的不同人群中可靶向基因组改变的患病率。
NPJ Precis Oncol. 2025 Jul 3;9(1):222. doi: 10.1038/s41698-025-00962-1.

本文引用的文献

1
Addressing racial and ethnic disparities in AACR project GENIE.解决美国癌症研究协会(AACR)项目GENIE中的种族和民族差异问题。
NPJ Precis Oncol. 2023 Aug 31;7(1):81. doi: 10.1038/s41698-023-00425-5.
2
Racial and ethnic disparities in a real-world precision oncology data registry.真实世界精准肿瘤学数据登记中的种族和民族差异。
NPJ Precis Oncol. 2023 Jan 19;7(1):7. doi: 10.1038/s41698-023-00351-6.
3
Racial Differences in Genomic Profiles of Breast Cancer.种族差异对乳腺癌基因组图谱的影响。
JAMA Netw Open. 2022 Mar 1;5(3):e220573. doi: 10.1001/jamanetworkopen.2022.0573.
4
Trends in Breast Cancer Incidence, by Race, Ethnicity, and Age Among Women Aged ≥20 Years - United States, 1999-2018.美国≥20 岁女性中乳腺癌发病率的种族、民族和年龄趋势 - 1999-2018 年。
MMWR Morb Mortal Wkly Rep. 2022 Jan 14;71(2):43-47. doi: 10.15585/mmwr.mm7102a2.
5
Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groups.肿瘤突变负担对不同种族群体的检查点抑制剂药物适用性和疗效的影响。
J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-003683.
6
Disparities in Tumor Mutational Burden, Immunotherapy Use, and Outcomes Based on Genomic Ancestry in Non-Small-Cell Lung Cancer.基于基因组起源的非小细胞肺癌肿瘤突变负担、免疫治疗应用和结局的差异。
JCO Glob Oncol. 2021 Sep;7:1537-1546. doi: 10.1200/GO.21.00309.
7
Structure-based classification predicts drug response in EGFR-mutant NSCLC.基于结构的分类预测 EGFR 突变型 NSCLC 的药物反应。
Nature. 2021 Sep;597(7878):732-737. doi: 10.1038/s41586-021-03898-1. Epub 2021 Sep 15.
8
FOXA1 overexpression suppresses interferon signaling and immune response in cancer.FOXA1过表达抑制癌症中的干扰素信号传导和免疫反应。
J Clin Invest. 2021 Jul 15;131(14). doi: 10.1172/JCI147025.
9
Mutations as Actionable Targets: A Paradigm Shift in the Management of Colorectal Cancer and Novel Avenues.可作为治疗靶点的突变:结直肠癌管理的范式转变及新途径
JCO Oncol Pract. 2021 Dec;17(12):723-730. doi: 10.1200/OP.21.00160. Epub 2021 Jun 2.
10
Race- and Age-Related Disparities in Cervical Cancer Mortality.宫颈癌死亡率的种族和年龄差异
J Natl Compr Canc Netw. 2021 Apr 1;19(7):789-795. doi: 10.6004/jnccn.2020.7665.